Research formulation combines BPC-157 and TB-500 for the experimental characterization of mucosal transport and systemic biodistribution. Investigated pathways include BPC-157-associated angiogenic and growth-factor signaling alongside TB-500-associated cell-migration, cytoskeletal, and inflammatory-response mechanisms.
For laboratory research use only. Not for human or veterinary use.
A liquid spray-format research blend containing BPC-157 and TB-500, with 30 mg total combined peptide content in a 15 mL bottle. The individual amount of each peptide is not specified here.
Preclinical research has examined BPC-157, TB-500, and their combination in areas such as:
| Total Content | Volume | Concentration | 0.1 mL | 0.2 mL | 0.4 mL | 1.0 mL |
|---|---|---|---|---|---|---|
| 30mg | 15mL | 2mg/mL | 0.2mg | 0.4mg | 0.8mg | 2mg |
Quantified to verify concentration within accepted labeled specification.
Assessed for peptide purity and absence of significant impurities by analytical methods.
Confirmed by analytical testing to match reference peptide characteristics.
Batch records and test data maintained for traceability and transparency.
Tested for potency, purity, and identity verification. COA generated for the current production batch.
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
No. It means 30 mg of total combined content.
That depends on the pump’s output volume. The amount per spray cannot be calculated from the bottle concentration alone.
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
